Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by ALCON RES LTD
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
020963
TIMOLOL MALEATE
New Drug Application
Approval
New formulation
(S) Standard review drug
062196
GENTAMICIN SULFATE
Abbreviated New Drug Application
Approval
064211
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
Abbreviated New Drug Application
Approval
074261
TIMOLOL MALEATE
Abbreviated New Drug Application
Approval
074262
TIMOLOL MALEATE
Abbreviated New Drug Application
Approval
074850
LEVOBUNOLOL HYDROCHLORIDE
Abbreviated New Drug Application
Approval
075720
METIPRANOLOL
Abbreviated New Drug Application
Approval
202565
BIMATOPROST
Abbreviated New Drug Application
Approval
203491
ILEVRO
New Drug Application
Approval
New manufacturer
(S) Standard review drug
204227
GATIFLOXACIN
Abbreviated New Drug Application
Approval
204251
SIMBRINZA
New Drug Application
Approval
New combination
(S) Standard review drug
206276
PAZEO
New Drug Application
Approval
New manufacturer
(P) Priority review drug
206307
XTORO
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
208135
TETRACAINE HYDROCHLORIDE
New Drug Application
Approval
Drug already marketed, but without an approved NDA
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval